These results have been published in the article “Disease Disparities by Socioeconomic Status and Diagnosis of Dementia in the Prescribing of Antipsychotics in a Real-World Data Population Over 60 Years of Age” in “Journal of Alzheimer’s”. An early online version of this paper detailing the findings has been published and is scheduled for publication in the Volume (100), Issue (2), of that journal on July 16, 2024.
DOI: 10.3233/JAD-240004
Authors: Mar, Javiera; b; c; * | Zubiagirre, Uxuea; b | Larrañaga, Igorc | Soto-Gordoa
About the Journal of Alzheimer’s Disease
Now in its 28th year of publication, the Journal of Alzheimer’s Disease (JAD) is an international multidisciplinary journal to facilitate progress in understanding the etiology, pathogenesis, epidemiology, genetics, behavior, treatment, and psychology of Alzheimer’s disease. The journal publishes research reports, reviews, short communications, book reviews, and letters-to-the-editor. Groundbreaking research that has appeared in the journal includes novel therapeutic targets, mechanisms of disease, and clinical trial outcomes. JAD has a Journal Impact Factor of 3.4 according to Journal Citation Reports (Clarivate, 2024). The journal is published by IOS Press. www.j-alz.com
About IOS Press
IOS Press is an international scientific, technical, medical (STM) publishing house established in 1987 in Amsterdam. We produce around 100 journals and 70 books annually in a broad range of subject categories, primarily specializing in health and life sciences (including neurosciences, medical informatics, cancer research, and rehabilitation) and computer sciences (including artificial intelligence, data science, and semantic web). In addition, we offer specialized services that support scientific advancement. www.iospress.com.